Analystreport

Voyager Therapeutics Inc (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at BTIG Research. They now have a $32.00 price target on the stock.

Voyager Therapeutics, Inc.  (VYGR) 
Last voyager therapeutics, inc. earnings: 3/3 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.voyagertherapeutics.com